Eurofarma, a Brazilian-based multinational pharmaceutical corporation operating in 22 countries, launched a new facial expression recognition experimental tool powered by artificial intelligence that enables patients with Parkinson’s disease to control their social media engagement using facial expressions.
The rise of smartphones, wearables, and health apps has fundamentally changed how people interact with their health.
Patients now have unprecedented access to health information, allowing them to monitor their well-being, track symptoms, research potential treatments, and even find digital tools to help with their condition.